Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study

被引：0

作者：

Rezende, Izabela M. ^{[1
,2
,9
]}

Mendonca, Diogo Correa ^{[3
]}

Costa, Thais Alkifeles ^{[2
]}

de Oliveria, Gabriela Fernanda Garcia ^{[2
]}

Arruda, Matheus Soares ^{[2
]}

Goncalves, Andreza Parreiras ^{[4
]}

Alves, Pedro Augusto ^{[4
]}

Calzavara-Silva, Carlos Eduardo ^{[5
]}

Martins-Filho, Olindo A. ^{[6
]}

Teixeira-Carvalho, Andrea ^{[6
]}

Bonjardim, Claudio Antonio ^{[2
]}

Monath, Thomas P. ^{[7
]}

LaBeaud, A. Desiree ^{[1
]}

Drumond, Betania P. ^{[2
]}

Pascoal-Xavier, Marcelo Antonio

Pereira, Leonardo S. ^{[8
,10
]}

Ramalho, Dario Brock ^{[8
,11
]}

机构：

[1] Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA USA

[2] Univ Fed Minas Gerais, Biol Sci Inst, Microbiol Dept, Lab Viruses, 6627 Antonio Carlos Ave Pampulha, BR-31270901 Belo Horizonte, MG, Brazil

[3] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Scotland

[4] Oswaldo Cruz Fdn Fiocruz, Rene Rachou Inst, Immunol Viral Dis, Belo Horizonte, MG, Brazil

[5] Oswaldo Cruz Fdn Fiocruz, Rene Rachou Inst, Cellular & Mol Immunol, Belo Horizonte, MG, Brazil

[6] Oswaldo Cruz Fdn Fiocruz, Rene Rachou Inst, Integrated Grp Biomarkers Res, Belo Horizonte, MG, Brazil

[7] Crozet Biopharm LLC, Lexington, MA USA

[8] Eduardo Menezes Hosp, Belo Horizonte, MG, Brazil

[9] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford Med Pandem Preparedness Hub, 240 Pasteur Dr Biomed Innovat Bldg BMI,3rd floor,R, Stanford, CA 94305 USA

[10] Bendigo Hlth, Bendigo, Vic, Australia

[11] Pan Amer Hlth Org, Brasilia, DF, Brazil

来源：

OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 06期

基金：

美国国家卫生研究院;

关键词：

antiviral; genomic viral load; sofosbuvir; yellow fever; yellow fever virus;

D O I：

10.1093/ofid/ofae312

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We enrolled 21 patients with laboratory-confirmed yellow fever (YF), hospitalized at Eduardo de Menezes Hospital, Brazil, to be treated with sofosbuvir, a drug approved for hepatitis C. Given the absence of specific YF antiviral treatments, the off-label nonrandomized sofosbuvir treatment aimed to address high disease severity and the risk of fatal outcomes. Patients received a daily dose of 400 mg sofosbuvir from 4 to 10 days post-symptom onset. YF viral load (VL) comparisons were made between treated and nontreated patients who either survived or died. The genomic VL for the treated group steadily decreased after day 7 post-symptom onset, suggesting that sofosbuvir might reduce YF VL. This study underscores the urgent need for YF antiviral therapies, advocating for randomized clinical trials to further explore sofosbuvir's role in YF treatment.

引用

页数：4

共 50 条

[1] Off-Label Yellow Fever and Hepatitis A Vaccination in Traveling Children
Muruzabal, Cecilia
Vicente, Lorea
Taravillo, Lucia Escolano
de Llano, Blanca Bravo Queipo
Calvo, Cristina
Hortelano, Milagros Garcia Lope
CHILDREN-BASEL, 2024, 11 (03):
[2] Propranolol for Off-label Treatment of Patients With Melanoma Results From a Cohort Study
De Giorgi, Vincenzo
Grazzini, Marta
Benemei, Silvia
Marchionni, Niccolo
Botteri, Edoardo
Pennacchioli, Elisabetta
Geppetti, Pierangelo
Gandini, Sara
JAMA ONCOLOGY, 2018, 4 (02)
[3] Cardiac Involvement by Yellow Fever During the 2018 Outbreak in Brazil: Data From the PROVAR plus Study
Paixao, Gabriela M.
Nunes, Maria Carmo P.
Beato, Bruno D.
Oliveira, Kaciane K.
Sable, Craig
Beaton, Andrea Z.
Rezende, Breno D.
Rios, Joao Pedro P.
Pereira, Leonardo S.
Teixeira, Maria Rita D.
Oliveira, Neimy R.
Xavier, Marcelo Antonio P.
Maciel, Gustavo, V
Brito, Camila Gabriela X.
Lima Junior, Moacir R.
Ribeiro, Antonio Luiz P.
Nascimento, Bruno R.
CIRCULATION, 2018, 138
[4] Clinical management of leprosy patients during the yellow fever outbreak in Brazil
Albuquerque, Rachel Gimenes
Tomimori, Jane
Floeter-Winter, Lucile Maria
Tufik, Sergio
Andersen, Monica Levy
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (06): : 503 - 504
[5] Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study)
Figueiredo-Mello, Claudia
Boas Casadio, Luciana Vilas
Avelino-Silva, Vivian Lida
Ho Yeh-Li
Sztajnbok, Jaques
Joelsons, Daniel
Antonio, Marilia Bordignon
Rebello Pinho, Joao Renato
Malta, Fernanda de Mello
Gomes-Gouvea, Michele Soares
Moreira Salles, Ana Paula
Cora, Aline Pivetta
Valente Moreira, Carlos Henrique
Ribeiro, Ana Freitas
de Seixas Santos Nastri, Ana Catharina
Sant'Ana Malaque, Ceila Maria
Azevedo Teixeira, Ralcyon Francis
Sansao Borges, Luciana Marques
Gonzalez, Mario Peribanez
Pereira Junior, Luiz Carlos
Lobato Souza, Tamara Newman
Wan Song, Alice Tung
Carneiro D'Albuquerque, Luiz Augusto
Abdala, Edson
Andraus, Wellington
de Martino, Rodrigo Bronze
Ducatti, Liliana
Andrade, Guilherme Marques
Se Malbouisson, Luiz Marcelo
de Souza, Izabel Marcilio
Carrilho, Flair Jose
Sabino, Ester Cerdeira
Levin, Anna S.
BMJ OPEN, 2019, 9 (11):
[6] Off-Label Closure During CLOSURE Study
Stackhouse, Kathryn A.
Goel, Sachin S.
Qureshi, Athar M.
Prieto, Lourdes
Kapadia, Samir
Tuzcu, E. Murat
Krasuski, Richard A.
JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (11): : 608 - 611
[7] Off-label use during pregnancy: analysis of the NeHaVi cohort
Blin, A.
Barbara, R.
Coubret, A.
Grau, M.
Aubard, Y.
Laroche, M. L.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 80 - 80
[8] Off-label prescribing during pregnancy in France: the NeHaVi cohort
Laroche, Marie-Laure
Blin, Aurora
Coubret, Anne
Grau, Muriel
Roux, Barbara
Aubard, Yves
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (04) : 198 - 207
[9] Early off-label treatment during pandemics? A dilemma
Jan, Roth A.
Tala, Ballouz
Roger, Kouyos D.
Manuel, Battegay
SWISS MEDICAL WEEKLY, 2020, 150
[10] Risk Factors for Acute Kidney Injury and Death in Patients Infected With the Yellow Fever Virus During the 2018 Outbreak in Sao Paulo, Brazil
Arantes, Marcia Fernanda
Seabra, Victor Faria
Gessolo Lins, Paulo Ricardo
Rodrigues, Camila Eleuterio
Reichert, Bernardo Vergara
Duarte Silveira, Marcelo Augusto
Li, Ho Yeh
Malbouisson, Luiz Marcelo
Andrade, Lucia
KIDNEY INTERNATIONAL REPORTS, 2022, 7 (03): : 601 - 609

← 1 2 3 4 5 →